Biotech Hansa Biopharma Reports Third Quarter and Interim Year to Date 2025 Financial Results October 30, 2025
Biotech NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem’s Shares October 29, 2025
Biotech Kanazawa University Research: Scanning nanoprobe microscope reveals the hidden flexibility of cancer cells October 29, 2025
Biotech FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy’s Disease October 23, 2025
Biotech SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform October 21, 2025
Biotech FDA Grants Orphan Drug Designation to Cellenkos’ CK0803 Tregs for Treatment of Amyotrophic Lateral Sclerosis October 20, 2025
Biotech PADCEV™ Plus KEYTRUDA™, Given Before and After Surgery, Cuts the Risk of Recurrence, Progression or Death by 60% and the Risk of Death by 50% for Certain Patients with Bladder Cancer October 19, 2025
Biotech FDA approves expanded pediatric indications for YUFLYMA® (adalimumab-aaty) and unbranded adalimumab-aaty in the United States October 17, 2025
Search
Biotech
October 30, 2025
October 29, 2025
October 29, 2025
October 26, 2025
October 23, 2025
October 21, 2025
October 20, 2025
October 19, 2025
October 18, 2025
October 17, 2025
